Aneurysmal Subarachnoid Hemorrhage Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the U.S. wherein 30,000 people are diagnosed for SAH each year. Among these cases, raptured cerebral aneurysms accounts for nearly 80% of the non-traumatic aneurysmal subarachnoid hemorrhage. Going forward, these numbers are expected to mount even further, and thereby prove to be boon for the players in the global market for aneurysmal subarachnoid hemorrhage.
Smoking, hypertension, history of intracranial aneurysms in immediate relatives, chronic alcohol use are some of the common causes of aneurysmal subarachnoid hemorrhage, while the symptoms include headache, facial or orbital pain, unilateral third nerve palsy, bilateral lower extremity weakness, and vision loss. With no absolute therapy available and severity of the implications, early detection of SAH is of utmost importance and hence, there are vast opportunities available for the players venturing in the aneurysmal subarachnoid hemorrhage market. In addition to that, the NIH study reveals that aneurysmal subarachnoid hemorrhage is more prevalent in developed region of North America including the U.S. in comparison to Japan and China in Asia Pacific. With the presence of several key players in the healthcare sector in North America, the research and development pertaining to aneurysmal subarachnoid hemorrhage is expected to drive the global aneurysmal subarachnoid hemorrhage market for the same.
Aneurysmal subarachnoid hemorrhage is a type of stroke and accounts for almost 7% of all strokes. It is listed under medical emergency conditions and can cause severe disability or can be fatal as well. Subarachnoid hemorrhage is sudden bleeding into the subarachnoid space of the central nervous system that may occur due to head injury, rupture of cerebral aneurysm, and aneurysm in other blood vessels. The most significant cause of aneurysmal subarachnoid hemorrhage is trauma. Some other causes of this condition are migraine, intra-cerebral hemorrhage, meningitis, and cerebral venous sinus thrombosis. In addition, lifestyle factors, smoking, genetics, hypertension, and excessive alcohol consumption are also significant factors for subarachnoid hemorrhage.
The report is an all-important tool to understand the progression of the global aneurysmal subarachnoid hemorrhage market between 2017 and 2025. In this report, the various market forces and growth indicators are analyzed at length to present a clear picture of strengths, weakness, threats, and opportunities of the market until the end of the forecast period in 2025.
The global aneurysmal subarachnoid hemorrhage market is segmented on the basis of diagnostic test, therapy, and geography. By diagnostic test, CT scan and MRI are the components of this market. Lumber puncture is mandatory in cases where imaging shows indefinite results. Xanthochromia is another diagnostic test that helps in the detection of aneurysmal subarachnoid hemorrhage. Cerebral angiography and transcranial Doppler ultrasound are also used for detecting aneurysmal subarachnoid hemorrhage.
The regional segments of the global aneurysm subarachnoid hemorrhage market are North America, Asia Pacific, Europe, and Rest of the World. As per an article published by Elsevier in 2014, countries such as Japan and Finland have high incidence rates of aneurysmal subarachnoid hemorrhage.
In May 2013, Arbor Pharmaceuticals received FDA approval for Nymalize containing nimodipine for patients with subarachnoid hemorrhage. Currently, Arbor Pharmaceuticals possess the commercial rights of Nymalize solely in the US.
The primary treatment for aneurysmal subarachnoid hemorrhage involves stabilizing the patient by repairing the cause of bleeding with the help of vasospasms such as calcium channel blockers such as nimodipine. Anti-anxiety medications and pain killers, when administered, helps relieve headaches and pressure in the skull. Phenyton is used to treat or prevent the occurrence of seizures.
The treatment also focuses on alleviating symptoms and preventing complications such as permanent brain damage. Surgery is advised in cases where removal of large volume of blood is required to alleviate pressure on the brain. Aneurysm clipping, endovascular coiling, and craniotomy are some of the surgical procedures carried out for aneurysmal subarachnoid hemorrhage. Endovascular coiling involves placing coils in the aneurysm and stents in the blood vessel in order to lessen risk of further bleeding.
Some of the leading companies in the global aneurysmal subarachnoid market are Arbor Pharmaceuticals, Edge Therapeutics Inc., and Actelion Ltd. Key institutions that contribute to the global aneurysmal subarachnoid hemorrhage market are Chinese University of Hong Kong, Utrecht University, University of Miami, University of Cambridge, and the University of Calgary among others.
This study provides a particularized anatomy according to the L.E.A.P mechanism
The regional analysis offers market assays across:
The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.
Latest Trends and Cardinal Growth Prospects
The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.
Existing and Future Insights in Growth
The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.
Ascensions in Technology
Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.
The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.
The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.
An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.
The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!
This report is the key to questions such as:
What are the prominent factors that will help in reshaping the market growth?
Which trends have the potential to bring expansive growth for the market?
What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?
Which regions will emerge as champion growth contributors for the market?
Which aspects will serve as game-changers for the market?
What are the latest innovations in the market?
Which factors will hinder the growth of the market?
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report